{"podcast":{"title":"The Automated Daily","slug":"the-automated-daily-6466996","podcast_index_feed_id":6466996,"rss_url":"https://theautomateddaily.com/feed.xml","website_url":"https://theautomateddaily.com","image_url":"https://theautomateddaily.com/logo.jpg","author":"TrendTeller","episode_count":100,"summary":"Welcome to 'The Automated Daily', your ultimate source for a streamlined and insightful daily news experience. Powered by cutting-edge Generative AI technology, we bring you the most crucial headlines of the day, carefully selected and delivered directly to your ears.","last_synced_at":"2026-08-01T02:17:22.579510+00:00","page_url":"https://stenobird.com/podcast/the-automated-daily-6466996"},"episode":{"title":"Breakthrough RAS drug for cancer & Personalized mRNA vaccine for melanoma - News (Jun 3, 2026)","slug":"breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma-news-jun-3-2026","published_at":"2026-06-03T13:45:58+00:00","page_url":"https://stenobird.com/podcast/the-automated-daily-6466996/breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma-news-jun-3-2026","show_page_url":"https://stenobird.com/podcast/the-automated-daily-6466996","url":"https://theautomateddaily.com/episodes/2026-06-03-breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma","audio_url":"https://dts.podtrac.com/redirect.mp3/cdn.theautomateddaily.com/audio/news/2026-06-03/en/episode.mp3","summary":"Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Breakthrough RAS drug for cancer - A major pancreatic cancer trial reports daraxonrasib, a broad RAS inhibitor, nearly doubled median survival—reviving hopes against long-\"undruggable\" targets like RAS and MYC. Personalized mRNA vaccine for melanoma - Five-year data suggest a personalized mRNA cancer vaccine plus Keytruda reduced melanoma recurrence and improved overall survival, strengthening the case for mRNA in oncology. New immunotherapy booster in lung cancer - A Scottish stage-four lung cancer patient describes meaningful tumor shrinkage in a trial of GRWD5769, a drug aimed at blocking cancer immune-escape and boosting immunotherapy response. Ultrasound wearable pacemaker progress - MIT researchers demonstrated a noninvasive, ultrasound-driven pacing approach using a small chest sticker and engineered heart cells, pointing toward surgery-free rhythm control for arrhythmias. Microsoft Majorana 2 quantum chip claims - Microsoft says its Majorana 2 quantum chip improves qubit stability dramatically, but scientists are asking for peer-reviewed evidence and clearer independent verification. AI worm risks from open models - University of Toronto researchers showcased a proof-of-concept \"AI worm\" that adapts across devices using open-weight models, raising urgent questions for cybersecurity and infrastructure defense. EU digital sovereignty push…","meta_description":"Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - Eff…","key_points":[],"chapters":[],"topics":[],"duration_seconds":527,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-automated-daily-6466996/episodes/breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma-news-jun-3-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-automated-daily-6466996/breakthrough-ras-drug-for-cancer-personalized-mrna-vaccine-for-melanoma-news-jun-3-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}